Skip to main content

Table 3 Changes of panic symptoms across the treatment, including effect sizes

From: Sensitization of catastrophic cognition in cognitive-behavioral therapy for panic disorder

  Cognitive I y Sensitized patients (N = 11) Cognitive Responding patients (N = 52)
  Baseline Post-treatment pa Effect sizeb Baseline Post-treatment pa Effect sizeb
ACQc 22.9(4.7) 27.7(5.0) .<000 -2.34 30.8(8.8) 20.7(6.1) <0.00 1.59
PDSSd-total 11.1(4.1) 9.1(4.4) .047 0.62 13.2(4.7) 5.9(4.3) <0.00 1.41
PDSSd-item        <0.00  
frequency of panic 1.1(0.5) 0.9(0.5) .317 0.30 1.3(0.9) 0.8(0.8) <0.00 0.56
distress duringpanic 2.4(1.1) 2.4(1.1) .732 0.03 2.5(1.4) 1.4(1.1) <0.00 0.70
anticipatory anxiety 1.2(1.1) 1.1(0.6) .792 0.08 1.9(1.0) 0.8(0.8) <0.00 1.01
agoraphobic fear/avoidance 2.0(1.0) 1.5(0.8) .107 0.53 2.2(1.1) 0.9(0.9) <0.00 1.08
interoceptive fear/avoidance 0.6(0.8) 0.7(0.9) .603 -0.15 1.2(1.1) 0.5(0.8) <0.00 0.60
impairment of work functioning 1.8(1.2) 1.5(1.3) .206 0.39 2.1(1.2) 0.7(1.2) <0.00 1.03
impairment of social functioning 2.0(1.0) 1.1(1.1) .039 0.74 2.1(1.1) 0.9(1.0) <0.00 1.08
FQ-age 13.6(12.2) 10.6(8.2) .153 0.42 13.2(9.8) 5.1(6.4) <0.00 0.79
MI-alonef 2.4(0.9) 2.1(0.7) .070 0.61 2.6(1.0) 1.7(0.7) <0.00 1.59
WHLS g 3.2(2.1) 2.4(1.8) .026 0.78 2.7(1.4) 1.3(1.3) <0.00 0.53
  1. a: Student's t-test for dependent samples or Wilcoxon rank-sumtest, b: Within-group effect size (ES) by Cohen's d. c:ACQ = Agoraphobic Cognitions Questionnaire, d:PDSS = Panic Disorder Severity Scale, e:FQ-ag = Fear Questionnaire-agoraphobia subscale, f:MI-alone = Mobility Inventory for agoraphobia-alone subscale, g:WHLS = The Work, Home and Leisure activities Scale